Case Report

Published on 11 Mar 2024

Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis

in Drug, Venom & Anaphylaxis

Loris Guyénard
Marie Tauber
Sophie Debord-Peguet
Frédéric Berard
Audrey Nosbaum
Florence Hacard
Mariana Castells
Jean-François Nicolas

Frontiers in Allergy

doi 10.3389/falgy.2024.1366922

500 views

Mini Review

Published on 07 Feb 2024

Recent findings on drug hypersensitivity in children

in Drug, Venom & Anaphylaxis

Mara Morelo Rocha Felix
Fábio Chigres Kuschnir
José Laerte Boechat
Mariana Castells

Frontiers in Allergy

doi 10.3389/falgy.2024.1330517

826 views

Brief Research Report

Published on 16 Jan 2024

Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG

in Drug, Venom & Anaphylaxis

Andy Ka Chun Kan
Valerie Chiang
Chinmoy Saha
Elaine Y. L. Au
Philip Hei Li

Frontiers in Allergy

doi 10.3389/falgy.2023.1331036

590 views

Correction

Published on 12 Jan 2024

Corrigendum: Approach for delabeling beta-lactam allergy in children

in Drug, Venom & Anaphylaxis

R. Sáenz de Santa María
G. Bogas
M. Labella
A. Ariza
M. Salas
I. Doña
M. J. Torres

Frontiers in Allergy

doi 10.3389/falgy.2023.1361973

450 views

Review

Published on 14 Dec 2023

Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy

in Drug, Venom & Anaphylaxis

Luís Gustavo Romani Fernandes
Edzard Spillner
Thilo Jakob

Frontiers in Allergy

doi 10.3389/falgy.2023.1327391

950 views

Review

Published on 15 Nov 2023

Approach for delabeling beta-lactam allergy in children

in Drug, Venom & Anaphylaxis

R. Sáenz de Santa María
G. Bogas
M. Labella
A. Ariza
M. Salas
I. Doña
M. J. Torres

Frontiers in Allergy

doi 10.3389/falgy.2023.1298335

1,589 views

Editorial

Published on 19 Sep 2023

Editorial: Antibiotic allergy de-labelling and management

in Drug, Venom & Anaphylaxis

Gigia Roizen
Patrick E. Beeler
Miguel Park
Mariana Castells
Elina Jerschow

Frontiers in Allergy

doi 10.3389/falgy.2023.1278690

718 views

Brief Research Report

Published on 31 Jul 2023

Use of a beta-lactam graded challenge process for inpatients with self-reported penicillin allergies at an academic medical center

in Drug, Venom & Anaphylaxis

Shawnalyn W. Sunagawa
Scott J. Bergman
Emily Kreikemeier
Andrew B. Watkins
Bryan T. Alexander
Molly M. Miller
Danny Schroeder
Erica J. Stohs
Trevor C. Van Schooneveld
Sara M. May

Frontiers in Allergy

doi 10.3389/falgy.2023.1161683

1,793 views

Case Report

Published on 27 Jul 2023

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report

in Drug, Venom & Anaphylaxis

Hassan Mobayed
Maryam Ali Al-Nesf
Karla Robles-Velasco
Ivan Cherrez-Ojeda
Luis Felipe Ensina
Marcus Maurer

Frontiers in Allergy

doi 10.3389/falgy.2023.1228495

1,212 views

Editorial

Published on 13 Jul 2023

Editorial: Assessment and management of adverse drug reactions in oncology

in Drug, Venom & Anaphylaxis

Ping-Feng Tsai
Kevin Sheng-Kai Ma

Frontiers in Allergy

doi 10.3389/falgy.2023.1223078

1,201 views

Original Research

Published on 04 Jul 2023

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles

in Drug, Venom & Anaphylaxis

Hannah S. Newton
Jenny Zhang
Duncan Donohue
Ragi Unnithan
Edward Cedrone
Jie Xu
Alison Vermilya
Tyler Malys
Jeffrey D. Clogston
Marina A. Dobrovolskaia

Frontiers in Allergy

doi 10.3389/falgy.2023.1126012

1,537 views
1 citation

Editorial

Published on 24 May 2023

Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals

in Drug, Venom & Anaphylaxis

Alexander Batista-Duharte
Salvador F. Aliño

Frontiers in Allergy

doi 10.3389/falgy.2023.1214914

783 views

Editorial

Published on 11 May 2023

Editorial: Diagnosis and management of allergy to chemotherapy and biologics

in Drug, Venom & Anaphylaxis

Ricardo Madrigal-Burgaleta
Mariana Castells

Frontiers in Allergy

doi 10.3389/falgy.2023.1205345

1,331 views
1 citation

Case Report

Published on 09 May 2023

Case report: Insulin desensitization as the only option for managing insulin allergy in a Sudanese patient

in Drug, Venom & Anaphylaxis

Rihan Said
Rayan Goda
Ihab B. Abdalrahman
Nahla H. H. Erwa

Frontiers in Allergy

doi 10.3389/falgy.2023.1089966

1,278 views

Brief Research Report

Published on 03 May 2023

Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization

in Drug, Venom & Anaphylaxis

Ibtihal AlOtaibi
Faisal Almuhizi
Shaonie Ton-Leclerc
Michael Fein
Christos Tsoukas
Lene Heise Garvey
Derek Lee
Moshe Ben-Shoshan
Ghislaine A. C. Isabwe
Ana M. Copaescu

Frontiers in Allergy

doi 10.3389/falgy.2023.1056619

1,369 views
1 citation

Brief Research Report

Published on 30 Mar 2023

A potential cost savings analysis of a penicillin de-labeling program

in Drug, Venom & Anaphylaxis

Yilu Dong
Tracy N. Zembles
Mark Nimmer
David C. Brousseau
David Vyles

Frontiers in Allergy

doi 10.3389/falgy.2023.1101321

1,271 views
1 citation

Navigation group

Articles

Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis

Recent findings on drug hypersensitivity in children

Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG

Corrigendum: Approach for delabeling beta-lactam allergy in children

Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy

Approach for delabeling beta-lactam allergy in children

Editorial: Antibiotic allergy de-labelling and management

Use of a beta-lactam graded challenge process for inpatients with self-reported penicillin allergies at an academic medical center

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report

Editorial: Assessment and management of adverse drug reactions in oncology

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles

Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals

Editorial: Diagnosis and management of allergy to chemotherapy and biologics

Case report: Insulin desensitization as the only option for managing insulin allergy in a Sudanese patient

Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization

A potential cost savings analysis of a penicillin de-labeling program